Your browser doesn't support javascript.
loading
Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.
Bennett, Iwan E; Field, Kathryn M; Hovens, Christopher M; Moffat, Bradford A; Rosenthal, Mark A; Drummond, Katharine; Kaye, Andrew H; Morokoff, Andrew P.
Afiliación
  • Bennett IE; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, 6th Floor, Clinical Sciences Building, Royal Parade, Parkville, VIC, 3050, Australia.
  • Field KM; Department of Medical Oncology, The Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.
  • Hovens CM; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, 6th Floor, Clinical Sciences Building, Royal Parade, Parkville, VIC, 3050, Australia.
  • Moffat BA; Department of Radiology, The Royal Melbourne Hospital, The University of Melbourne, 1st Floor, 300 Grattan St, Parkville, VIC, 3050, Australia.
  • Rosenthal MA; Department of Medical Oncology, The Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.
  • Drummond K; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, 6th Floor, Clinical Sciences Building, Royal Parade, Parkville, VIC, 3050, Australia.
  • Kaye AH; Department of Neurosurgery, The Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.
  • Morokoff AP; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, 6th Floor, Clinical Sciences Building, Royal Parade, Parkville, VIC, 3050, Australia.
J Neurooncol ; 131(2): 321-329, 2017 01.
Article en En | MEDLINE | ID: mdl-27896520

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carboplatino / Glioblastoma / Angiografía por Resonancia Magnética / Bevacizumab / Antineoplásicos Inmunológicos / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carboplatino / Glioblastoma / Angiografía por Resonancia Magnética / Bevacizumab / Antineoplásicos Inmunológicos / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Australia